Lipid imbalance in Yakutsk residents when infected with the SARS-CoV-2 virus and in the post-covid period
https://doi.org/10.25789/YMJ.2022.80.21
Abstract
According to the results of the study, when infected with the SARS-CoV-2 virus, lipid metabolism is disturbed: in the acute period of infection, the level of total cholesterol decreases, in the post-COVID period, its level significantly increases. The most pronounced shift in the lipid profile towards atherogenicity occurs in patients who recovered from COVID-19 three months ago due to a decrease in the antiatherogenic fraction of lipids. Dyslipidemia is most pronounced in patients who have had an infection with severe lung damage (50-75%) due to an increase in atherogenic lipid fractions that create a risk of atherosclerosis.
About the Authors
A. I. Yakovleva
Yakut Science Centre for Complex Medical Problems
Russian Federation
Russian Federation
akovleva Alexandra Ivanovna – researcher, Laboratory of Biochemical and Immunological Research
L D. Olesova
Yakut Science Centre for Complex Medical Problems
Russian Federation
Russian Federation
Olesova Lyubov Dygynovna – external researcher, Laboratory of Biochemical and Immunological Research
E. D. Okhlopkova
Yakut Science Centre for Complex Medical Problems
Russian Federation
Russian Federation
Okhlopkova Elena Dmitrievna – senior researcher, Laboratory of Biochemical and Immunological Research
References
1. Ben-Aicha S, Badimon L, Vilahur G. Advances in HDL: Much More than Lipid Transporters. International Journal of Molecular Sciences. 2020; 21(3): 732. – DOI: 10.3390/ijms21030732.
2. Banach M., Penson P. E., Fras X. Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic. Pharmacological Research. 2020. DOI: 10.1016/j.phrs.2020.104891.
3. Yan B., Chu H., Yang D. [et al]. Characterization of the Lipidomic Profile of Human Coronavirus-Infected Cells: Implications for Lipid Metabolism Remodeling upon Coronavirus Replication. Viruses. 2019; 11(1): 73. DOI: 10.3390/v11010073.
4. Peng Y, Wan L., Fan C., Zhang P. [et al]. Cholesterol Metabolism—Impacts on SARS-CoV-2 Infection Prognosis MedRxiv. 2020. DOI: 10.1101/2020.04.16.20068528
5. Hu X., Chen D., Wu L. [et al]. Declined serum high density lipoprotein cholesterol is associated with the severity of COVID-19 infection. Clinica Chimica Acta. 2020; 510: 105-110. DOI: 10.1016/j.cca.2020.07.015.
6. Mineo Ch, Deguchi H, Griffin J. H. [et al]. Endothelial and antithrombotic actions of HDL. Circulation Research. 2006; 98(11): 1352-1364. DOI: 10.1161/01.RES.0000225982.01988.93.
7. Feingold K. R., Anawalt B., Boyce A. [et al]. Introduction to Lipids and Lipoproteins In: Endotext [Internet]. South Dartmouth (MA): MD Text. com, Inc. 2021. PMID: 26247089. Bookshelf ID: NBK305896.
8. Baglivo M., Baronio M., Natalini G. [et al]. Natural small molecules as inhibitors of coronavirus lipid-dependent attachment to host cells: a possible strategy for reducing SARS-COV-2 infectivity? Acta Biomed. 2020; 91(1): 161-164. DOI: 10.23750/abm.v91i1.9402.
9. Wierdsma NJ, Kruizenga HM, Konings LA [et al]. Poor nutritional status, risk of sarcopenia and nutrition related complaints are prevalent in COVID-19 patients during and after hospital admission. Clin Nutr ESPEN. 2021. Jun; 43: 369-376. doi: 10.1016/j.clnesp.2021.03.021. Epub 2021 Apr 20. PMID: 34024542; PMCID: PMC8056328.
10. Chen X., Xiao Huang, Tian H. [et al]. Prognostic value of PCSK9 and blood lipid in patients with sepsis. Kong Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022; 34(6): 614-619. DOI: 10.3760/cma.j.cn121430-20211220-01887.
11. Abu-Farha M., Thanaraj Th. A., Qaddoumi M. G. [et al]. Role of Lipid Metabolism in COVID-19 Virus Infection and as a Drug Target. International Journal of Molecular Sciences. 2020; 21(10). DOI: 10.3390/ijms21103544.
Review
For citations:
Yakovleva A.I., Olesova L.D., Okhlopkova E.D. Lipid imbalance in Yakutsk residents when infected with the SARS-CoV-2 virus and in the post-covid period. Yakut Medical Journal. 2022;(4):79-83. https://doi.org/10.25789/YMJ.2022.80.21
Views:
37
Email this article 